Puma Biotechnology (PBYI) Free Cash Flow (QoQ) (2011 - 2026)
Puma Biotechnology (PBYI) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Puma Biotechnology | 408.29 Mn | 370.00 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.65% |
| Dec 31, 2025 | 50.70% |
| Sep 30, 2025 | -32.13% |
| Jun 30, 2025 | 298.00% |
| Mar 31, 2025 | -77.19% |
| Dec 31, 2024 | 41.20% |
| Sep 30, 2024 | 984.37% |
| Jun 30, 2024 | -90.96% |
| Mar 31, 2024 | 7.83% |
| Dec 31, 2023 | -1.89% |
| Sep 30, 2023 | 222.51% |
| Jun 30, 2023 | 24.71% |
| Mar 31, 2023 | -65.60% |
| Dec 31, 2022 | -55.48% |
| Sep 30, 2022 | 224.40% |
| Jun 30, 2022 | 48.41% |
| Mar 31, 2022 | -394.85% |
| Dec 31, 2021 | -151.77% |
| Sep 30, 2021 | 14,286.49% |
| Jun 30, 2021 | -100.47% |